Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.
Christopher E CollinsJosefina Cortes-HernándezMercedes A GarciaJohannes von KempisAndreas SchwartingZahi ToumaMilena KurtineczKerry GairyPublished in: Rheumatology and therapy (2020)
Belimumab improves clinical manifestations of SLE and is associated with GCS dose reductions in a real-world clinical setting, supporting the real-world effectiveness of belimumab for SLE.